Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Plebani

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Nature Immunology|December 27, 2011
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleenIrene Puga, Montserrat Cols, Carolina M Barra, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.
European Journal of Immunology|May 14, 2022
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiencyGiulia Milardi, Biagio Di Lorenzo, Jolanda Gerosa, et al.
The World Allergy Organization Journal|April 3, 2019
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the worldZeinab A El-Sayed, Irina Abramova, Juan Carlos Aldave, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|September 27, 2020
Coronavirus disease 2019 in patients with inborn errors of immunity: An international studyIsabelle Meyts, Giorgia Bucciol, Isabella Quinti, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Nature Immunology|December 27, 2011
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleenIrene Puga, Montserrat Cols, Carolina M Barra, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.
European Journal of Immunology|May 14, 2022
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiencyGiulia Milardi, Biagio Di Lorenzo, Jolanda Gerosa, et al.
The World Allergy Organization Journal|April 3, 2019
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the worldZeinab A El-Sayed, Irina Abramova, Juan Carlos Aldave, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|September 27, 2020
Coronavirus disease 2019 in patients with inborn errors of immunity: An international studyIsabelle Meyts, Giorgia Bucciol, Isabella Quinti, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
Pageof 19